CANSLIM Stock Screener – 2026-09-16 (125 Stocks)

Posted on by Andrew

The 125 names passing the CAN SLIM stock screener are heavily clustered in two software categories, with Software – Infrastructure contributing 28 stocks and Software – Application adding 23. Oil & Gas Refining & Marketing is a distant third at 8 names. This distribution suggests leadership is concentrated in technology rather than spread broadly across sectors.

Ten names appear on two or more screens, the strongest form of cross-confirmation in this run: NET, CRM, DELL, ECO, IOT, NTAP, RBRK, S, SNOW, and TEAM. Eighteen names are new to the list versus the prior trading day, including AMD, CHRD, DDS, DXCM, EVER, FEIM, FROG, NTNX, OVV, PR, SAIC, SCHW, SEIC, TENB, TWLO, VEEV, WHD, and WKC. Twenty names dropped off, among them AAMI, AOUT, ASO, CGAU, EC, ERO, ETON, FLYW, LGND, NESR, ONC, PAYS, PCOR, RIOT, ROKU, SMCI, TRMD, TYL, UVE, and VCTR.

Among CANSLIM stocks selected by all three screens, NET is described as advancing within a deep base that has not yet matured, with a depth of 17.6% and 4.4 weeks of formation, and a pivot at $330.83. The shallow time frame relative to the base depth indicates the structure is still building rather than complete. No other names in this group carry technical notes in the fact sheet.

For educational purposes only — not investment advice.

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts